Shares and AJ Bell Investor Evening Presentation

Shares and AJ Bell Investor Evening Presentation

CEO, Prof. Cath O'Neill presenting at the AJ Bell Investor Evening https://youtu.be/pol8NsE_of4...

22nd June, 2018 Read More

SkinBioTherapeutics to fulfil industrial partner role in skin health research grant awarded to the University of Manchester

SkinBioTherapeutics to fulfil industrial partner role in skin health research grant awarded to the University of Manchester

Manchester, UK - 29 May 2018 - SkinBioTherapeutics plc (AIM: SBTX, the 'Company'), a life science company focused on skin health, announces its collaboration as industrial partner in a grant awarded by the Biotechnology and Biological Sciences Research Council (BBSRC) to The University of Mancheste...

29th May, 2018 Read More

Shares and AJ Bell Investor Evening

Shares and AJ Bell Investor Evening

SkinBioTherapeutics to present on 20 June 2018 at the Shares and AJ Bell Spotlight Evening in London. Shareholders and potential investors can register now for free at: http://www.sharesmagazine.co.uk/events...

29th May, 2018 Read More

Health Europa

Health Europa

SkinBioTherapeutics is featured in the latest edition of the Health Europa Quarterly publication...

16th May, 2018 Read More

SkinBioTherapeutics files new patent application

SkinBioTherapeutics files new patent application

Manchester, UK - 14 May 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, announces a new patent filing. The patent application is to cover the use of SkinBiotix® for increasing filaggrin levels in skin....

14th May, 2018 Read More

SkinBioTherapeutics finalises plans for human study of cosmetic application and progresses manufacturing scale-up

SkinBioTherapeutics finalises plans for human study of cosmetic application and progresses manufacturing scale-up

Manchester, UK - 01 May 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, is pleased to provide the following update: Human study The design of the human study planned for Q3 2018 has now been finalised. This will be conducted ind...

1st May, 2018 Read More
investors logo